Buse, John B, et al. “Long-Term Efficacy and Safety of Oral Semaglutide and the Effect of Switching from Sitagliptin to Oral Semaglutide in Patients With Type 2 Diabetes: A 52-Week, Randomized, Open-Label Extension of the PIONEER 7 Trial”. 2020. BMJ Open Diabetes Research & Care, vol. 8, no. 2, 2020.